HISTORY
2022
- ·Obtained Accreditation certificate of foreign drug manufacturer (Japan Ministry of Health , Labour and Welfare)
2021
- ·GMP compliance certified by Ministry of Food and Drug Safety
- ·antihistamines registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
- ·hyperlipidemia registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
- ·Patent application for Crystalline form of Ilaprazole sodium and its new process
2020
- ·antipeptic ulcer drug registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
- ·antihistamines registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
- ·antiarrhythmic drug registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
- ·Patent application for Process for the crystalline form of Ilaprazole
- ·Patent application for New process for preparation of Edoxaban benzenesulfonate monohydrate
- ·Patent application for New process for the preparation of Tenofovir alafenamide hemi-tartrate
2019
- ·Awarded US$10million export tower prize
- ·GMP compliance certified by Japan Pharmaceuticals and Medical Devices Agentcy
- ·Patent application for Crystal form of Valsartan-Sacubitril 3 Sodium hydrate and Method for the preparation thereof
- ·Patent application for Crystal of Edoxaban benzenesulfonate monohydrate and its preparing method
2018
- ·GMP compliance certified by Ministry of Food and Drug Safety
- ·Patent application for Crystal form I of teneligliptin ditosylate dihydrate and preparation process thereof
- ·Patent application for Crystal form I of Ticagrelor Fumarateand its preparing method
2017
- ·Obtained Accreditation certificate of foreign drug manufacturer (Japan Ministry of Health , Labour and Welfare)
2016
- ·antimicrobial agent registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
2015
- ·Completion of 2nd manufacturing building of Hwaseong GMP factory
- ·GMP compliance certified by Ministry of Food and Drug Safety
2014
- ·GMP compliance certified by Japan Pharmaceuticals and Medical Devices Agentcy
- ·antihistamines registered/asthma in Japanese Ministry of Health, Labor and Welfare (JDMF)
2013
- ·Honored with R&D Award in the 2013 Gyeonggi Science and Technology performance fair
- ·Industry-university cooperation agreement with Daegu Catholic University
- ·Patent application for A Novel Method for Preparing of Telmisartan
- ·Patent application for A Novel Method for Preparing Fexofenadine HCl
2012
- ·Completion of R&D center
- ·Patent application for A preparation method of (S)-dapoxetine hydrochloride
2011
- ·Established an Intra-company welfare foundation
- ·Selected as a promising company by Gyeonggi-do
- ·immunosuppressive drug registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
- ·antihistamines registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
2009
- ·Patent application for Novel Methods for Preparing Mosapride
2008
- ·antimicrobial agent registered in Japanese Ministry of Health, Labor and Welfare (JDMF)
- ·Obtained INNO-BIZ (Small and Medium Business Administration)
- ·Patent application for Methods for preparing biphenyl benzoic acid derivatives
- ·Patent application for Methods of removing the triphenylmethane protection group
- ·Patent application for Manufacturing Process of Optically Active [6-2-(Aminoethyl)-(4R,6R)-2,2-dimethyl-[1,3]dioxan-4-yl ]acetic acid Derivative as Intermediate of Atorvastatin
- ·Patent application for Process for the preparation of optically active 5-hydroxy-3-oxoheptanoate derivatives
- ·Patent application for Manufacturing Process of 2-Aminomalonamide as Intermediate for Producing 4-Carbamoyl-1-β-D-ribofuranosylimidazolium-5-olate
2007
- ·Obtained Accreditation certificate of foreign drug manufacturer (Japan Ministry of Health , Labour and Welfare)
- ·Expansion of Hwaseong factory
2006
- ·Hwaseong factory BGMP Approval (by Ministry of Food and Drug Safety)
- ·Completion of Hwaseong BGMP factory and production launching
2005
- ·Construction of Hwaseong BGMP factory
- ·Patent application for Methods of preparing 2-[2-(3-methoxyphenyl)ethyl]phenol and intermediate thereof under palladium catalysis
- ·Established Pharmacostech Co., Ltd. Central Research Center (Korea Industrial Technology Association)
2004
- ·Obtained ISO 9001 certification
2002
- ·Approved as a Clean Workplace (by Ministry of Labor)
2001
- ·Completion of Eumseong factory / Operation launching
2000
- ·Established Pharmacostech Co., Ltd.